|
業務類別
|
Biotechnology |
|
業務概覽
|
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics. |
| 公司地址
| 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731 |
| 電話號碼
| +1 512 501-2444 |
| 傳真號碼
| +1 512 501-0414 |
| 公司網頁
| https://www.cassavasciences.com |
| 員工數量
| 30 |
| Dr. Jack Moore |
Senior Vice President, Clinical Development |
-- |
21/04/2025 |
| Mr. Richard J. Barry |
President, Chief Executive Officer and Director |
美元 309.38K |
14/04/2025 |
| Mr. Remi Barbier |
Chairman of the Board, President and Chief Executive Officer |
美元 1.19M |
26/03/2024 |
| Dr. Nadav Friedmann, M.D.,PhD |
Director and Chief Medical Officer |
美元 365.00K |
24/03/2022 |
| Dr. James W. Kupiec, M.D. |
Chief Medical Officer |
美元 449.00K |
21/04/2025 |
| Mr. R. Christopher Cook |
Chief Operating and Legal Officer |
-- |
21/04/2025 |
| Mr. Eric J. Schoen |
Chief Financial Officer and Principal Accounting Officer |
美元 475.00K |
21/04/2025 |
| Ms. Freda Nassif |
Chief Business Officer |
-- |
14/04/2025 |
|
|
| Dr. Claude Nicaise,M.D. |
Chairman of the Board |
14/04/2025 |
| Mr. Richard J. Barry |
President, Chief Executive Officer and Director |
14/04/2025 |
| Dr. Patrick J. Scannon,M.D.,PhD |
Independent Director |
14/04/2025 |
| Mr. Remi Barbier |
Chairman of the Board, President and Chief Executive Officer |
26/03/2024 |
| Ms. Dawn Carter Bir |
Independent Director |
22/10/2025 |
| Dr. Nadav Friedmann, M.D.,PhD |
Director and Chief Medical Officer |
24/03/2022 |
| Mr. Sanford R. Robertson |
Lead Independent Director |
26/03/2024 |
| Mr. Pierre Gravier |
Independent Director |
14/04/2025 |
| Mr. Michael J. O'Donnell, Esq. |
Independent Director |
14/04/2025 |
| Dr. Robert Z. Gussin, PhD |
Independent Director |
14/04/2025 |
| Mr. Robert Anderson, Jr |
Independent Director |
14/04/2025 |
|
|
|
|
